BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21749497)

  • 21. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve.
    Lawson LJ; Frost L; Risbridger J; Fearn S; Perry VH
    J Neurocytol; 1994 Dec; 23(12):729-44. PubMed ID: 7897440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathology of peripheral nerves (elementary lesions, their development and different types of neuropathies) (1st part)].
    Salisachs P
    Sem Hop; 1975 Jan; 51(5):311-9. PubMed ID: 169574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent data on Schwann cells].
    Massiou H; Hauw JJ; Bourre JM; Jacque C; Baumann N
    Pathol Biol (Paris); 1984 Jan; 32(1):59-69. PubMed ID: 6322095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic induction of the Ink4a/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge.
    Gomez-Sanchez JA; Gomis-Coloma C; Morenilla-Palao C; Peiro G; Serra E; Serrano M; Cabedo H
    Brain; 2013 Jul; 136(Pt 7):2262-78. PubMed ID: 23748155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heme Oxygenase 1 in Schwann Cells Regulates Peripheral Nerve Degeneration Against Oxidative Stress.
    Kim M; Kim H; Kim D; Kim D; Huh Y; Park C; Chung HJ; Jung J; Jeong NY
    ASN Neuro; 2019; 11():1759091419838949. PubMed ID: 31046408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization of degenerating axons in a dysmyelinating mouse mutant with axonal loss.
    Ey B; Kobsar I; Blazyca H; Kroner A; Martini R
    Mol Cell Neurosci; 2007 May; 35(1):153-60. PubMed ID: 17383197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the V-ATPase subunit ATP6V0D2 and its role in demyelination after peripheral nerve injury.
    Shin YK; Jo YR; Lee SH; Park HT; Shin JE
    Biochem Biophys Res Commun; 2023 Feb; 646():1-7. PubMed ID: 36689911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
    Simonin Y; Perrin FE; Kato AC
    J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial swelling and microtubule depolymerization are associated with energy depletion in axon degeneration.
    Park JY; Jang SY; Shin YK; Koh H; Suh DJ; Shinji T; Araki T; Park HT
    Neuroscience; 2013 May; 238():258-69. PubMed ID: 23485808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
    Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
    Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axons modulate the expression of transforming growth factor-betas in Schwann cells.
    Scherer SS; Kamholz J; Jakowlew SB
    Glia; 1993 Aug; 8(4):265-76. PubMed ID: 8406683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Neuronal Nitric Oxide Synthase by Ethyl Pyruvate in Schwann Cells Protects Against Peripheral Nerve Degeneration.
    Chung HJ; Kim M; Jung J; Jeong NY
    Neurochem Res; 2019 Aug; 44(8):1964-1976. PubMed ID: 31218567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.
    Park HT; Kim YH; Lee KE; Kim JK
    Cell Mol Life Sci; 2020 Jul; 77(13):2497-2506. PubMed ID: 31884566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration.
    Liu HM; Yang LH; Yang YJ
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):487-96. PubMed ID: 7602323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury.
    Jung J; Jo HW; Kwon H; Jeong NY
    Biomed Res Int; 2014; 2014():936891. PubMed ID: 25101301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axonal lesions in acute experimental demyelination: a sequential teased nerve fiber study.
    Said G; Saida K; Saida T; Asbury AK
    Neurology; 1981 Apr; 31(4):413-21. PubMed ID: 7194432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration.
    Fruttiger M; Schachner M; Martini R
    J Neurocytol; 1995 Jan; 24(1):1-14. PubMed ID: 7539482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.